Dependence

FDA approves test for opioid use disorder risk assessment
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has approved a test designed to determine if a patient is at risk of developing opioid use disorder (OUD).
December 21, 2023
Pills Bottle Social
Medicare paid $704.2M for drug testing at risk of noncompliance with requirements
By LabPulse.com staff writers
In an audit, the Office of Inspector General identified Medicare Part B payments for drug testing services that were at risk for noncompliance with Medicare requirements.
March 1, 2023
Money Hundred Bills Social
Axim Biotechnologies developing point-of-care assay to measure fentanyl neutralizing antibodies
By LabPulse.com staff writers
Recent research suggests that fentanyl neutralizing antibodies may prevent overdose deaths, but scientists will need to quantitatively measure a patient's neutralizing antibodies through clinical studies and for relapse prevention.
January 18, 2023
Alcohol Drugs Pills Social
GBS to acquire drug screening firm Intelligent Fingerprinting
By LabPulse.com staff writers
The acquisition would enable the combination of Intelligent Fingerprinting's sweat-based drug screening technology with the GBS saliva-based glucose biosensor platform and manufacturing expertise, GBS said.
June 15, 2022
2020 09 08 18 51 2374 Business Handshake Meeting 400
Scientists develop new rapid, onsite THC assay
By LabPulse.com staff writers
The THC assay -- dubbed express probe for onsite cannabis inhalation (EPOCH) -- can detect the compound with high sensitivity and provide results within five minutes, according to the research group, led by Hojeong Yu, PhD, of Harvard Medical School.
October 28, 2021
2021 10 29 19 53 8921 Marijuana 400
Beckman Coulter launches DxU Iris urinalysis system at AACC
By LabPulse.com staff writers
DxU Iris is designed to reduce manual sample processing in urinalysis lab workflow by reducing manual reviews to 4%. This can cut sample processing time by up to 78%, according to the company.
September 27, 2021
2021 09 28 17 08 4382 2021 09 28 Beckman Urinalysis Solution 400
Abnormal urine drug tests common in cancer patients
By Emily Hayes
Approaches vary for monitoring cancer patients who are prescribed opioids on a long-term basis. Patients may be selected on a random basis, or, alternatively, screening may be focused on those with a higher likelihood of abuse.
February 6, 2020
2020 02 06 00 21 0816 Lab Urine Test Strip 400
Siemens expands opioid testing menu with fentanyl assay
By LabPulse.com staff writers
The test is capable of detecting fentanyl and its principal metabolite norfentanyl. Being able to identify both fentanyl and norfentanyl prolongs the time window for detecting fentanyl in urine with chemistry analyzers, giving laboratories more time to identify true positives, according to the company.
January 15, 2020
2020 01 15 23 19 8499 Siemens Rsna 2019 400
CDC finds vitamin E acetate in 100% of vaping cases
By Brian Casey
The discovery reinforces suspicion that vitamin E acetate is the cause of a series of cases of what the CDC has dubbed EVALI (e-cigarette, or vaping, product use-associated lung injury). It is believed that the substance is added to cannabinoid products sold online that have not been approved by the U.S. Food and Drug Administration.
November 7, 2019
2019 10 30 23 55 4011 2019 10 31 Vaping Cta 20191030233752
Abbott, Intoximeters partner on roadside drug test
By LabPulse.com staff writers
The SoToxa mobile test uses a swab from the mouth, cheek, and gums, and results are available within five minutes, according to Abbott. The company is positioning the product as a more convenient alternative to blood testing.
August 14, 2019
2019 08 15 18 10 0915 Police Cars Emergency 400
AACC: Labs should be aware of false positives on THC drug screens
By Emily Hayes
Cannabinol (CBN), which is marketed as an over-the-counter sleep aid, gave a positive result on one of two THC immunoassays tested in a study of urine samples taken at ARUP Laboratories, a nationwide clinical and anatomical pathology reference laboratory and a nonprofit arm of the University of Utah. Specifically, CBN gave a positive result on the Emit II Plus assay on a Beckman Coulter AU5810 instrument, but it did not give a positive result with the Microgenics MultiGent test on the Abbott Architect product, the researchers reported.
August 5, 2019
2019 08 05 17 59 6641 Aacc 2019 400
AACC calls for joint effort to tackle opioid epidemic
By LabPulse.com staff writers
The number of fatal overdoses caused by synthetic opioids increased by 46% in the U.S. from 2016 to 2017 and formed a large proportion of the roughly 70,000 drug overdose deaths in 2017, according to the AACC. Clinical laboratories have the experts, tools, and tests to identify synthetic opioids that are otherwise generally missed.
August 4, 2019
2019 08 05 19 09 1932 Bottle Pills 400
Page 1 of 2
Next Page